GENTIUM S.R.L.
7Patents
7Active
7Granted
52Portfolio score
Filing activity: Jul 3, 2014 → Aug 27, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9539277B2 | Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (GVHD) | Chemistry; Metallurgy | 6 | Active |
| US9867843B2 | Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (GVHD) | Chemistry; Metallurgy | 3 | Active |
| US10393731B2 | Cellular-based method for determining the biological activity of defibrotide | Physics | 3 | Active |
| US11085043B2 | Euglobulin-based method for determining the biological activity of defibrotide | Chemistry; Metallurgy | 2 | Active |
| US11236328B2 | Euglobulin-based method for determining the biological activity of defibrotide | Chemistry; Metallurgy | 1 | Active |
| US11746348B2 | Euglobulin-based method for determining the biological activity of defibrotide | Chemistry; Metallurgy | 0 | Active |
| US9782429B2 | Formulation having mobilizing activity | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.